InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Schall Thomas J., Chairman & CEO. Insider active across 1 company, notably ChemoCentryx, Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 1 December 2021. The latest transaction was disclosed on 1 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
23,334 shares0Common StockSEC:0001209191-22-001341
23,334 shares0Common StockSEC:0001209191-22-001341:0
38,948 shares@ US$10.270.062% mcap100.0% of flowCommon StockSEC:0001209191-21-068010
38,948 shares@ US$10.270.062% mcap50.0% of flowCommon StockSEC:0001209191-21-068010:0
4 of 4 declarations
About Schall Thomas J.
Schall Thomas J. is the President and CEO of ChemoCentryx, Inc. He leads the company in developing innovative treatments for autoimmune diseases, overseeing operations and research strategy.
